Medication compliance and persistence: terminology and definitions.

By J. Cramer, A. Roy, A. Burrell, C. Fairchild, M. Fuldeore, D. Ollendorf, P. Wong. Value in Health, 2008

2,268 citations recorded by the source corpus.

Subfields: Family Practice, Geriatrics and Gerontology, Statistics and Probability

View Paper: https://www.semanticscholar.org/paper/a66cca66b3bb9c5e4e2f469a8151bc57f3d2ba2d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Family Practice

1. L. García‐Pérez
2. Vicente Francisco Gil-Guillén
3. Domingo Orozco-Beltrán
4. T. Dilla
5. M. Alvarez

In Statistics and Probability

1. Katherine P. Liao
2. Tamara M. Haegerich
3. D. Dowell

Citations in the corpus

• Adherence to Therapies in Patients with Type 2 Diabetes (2013, background): “Treatment persistence is usually defined as the duration of time that a patient continues treatment as a proportion of the prescribed duration [9].”
• National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. (2015, background): “, face to face, phone, email, text, messaging via electronic record) will likely be beneficial for increasing adherence.(764,791,794) In the era of the Patient Centered Medical Home, patient-determined goals and action steps are critical to positive outcomes.”
• CDC guideline for prescribing opioids for chronic pain (2016, background): “In general, patient compliance to medication is poor (22-24) and studies suggest this is also true for people with chronic pain using opioids.”